Geopolitics Alpha

Q2 earnings highs and lows: Eli Lilly (NYSE:LLY) vs the rest of the branded pharmaceuticals stocks

Published . Updated .

Q2 earnings highs and lows: Eli Lilly (NYSE:LLY) vs the rest of the branded pharmaceuticals stocks

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Eli Lilly (NYSE:LLY) and the best and worst performers in the branded pharmaceuticals industry.

Directly affected

  • LLY Eli Lilly+14.8%

    Named in this report.

Indirectly affected

  • No related companies are mapped for this report yet.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
LLY-2.64%-0.26%baseafter closeafter closeafter closeafter close

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Q2 earnings highs and lows: Eli Lilly (NYSE:LLY) vs the rest of the branded pharmaceuticals stocks Yahoo Finance

Source: Yahoo Finance

This story

CompanyWhenMoveStatus
GLDthree days earlier+3.37%final price
GLDfive days earlier+3.56%final price
LLYthree days earlier-0.26%final price
LLYfive days earlier-2.64%final price
QQQthree days earlier+2.99%final price
QQQfive days earlier+2.00%final price
SPYthree days earlier+1.75%final price
SPYfive days earlier+0.89%final price
TLTthree days earlier-1.35%final price
TLTfive days earlier-2.31%final price

This story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

This story

12 out of 100

“Q2 earnings highs and lows: Eli Lilly (NYSE:LLY) vs the rest of the branded pharmaceuticals stocks” scores 12 out of 100. The score uses 1 sources.